Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.89M Sell
736,845
-323,376
-31% -$936K 1.49% 29
2025
Q4
$2M Buy
+1,060,221
New +$1.96M 0.96% 41
2024
Q4
Sell
-262,625
Closed -$583K 61
2024
Q3
$583K Buy
262,625
+111,749
+74% +$294K 0.39% 54
2024
Q2
$462K Sell
150,876
-4,507
-3% -$12.1K 0.41% 47
2024
Q1
$435K Buy
+155,383
New +$484K 0.37% 50

Other funds holding ADAG

Exome Asset Management's ADAG Position: Q1 2026 in Review

Exome Asset Management reduced its Adagene (ADAG) stake by 31% in Q1 2026, selling an estimated $936K and leaving 736,845 shares worth $2.89M. The position accounts for 1.49% of the portfolio, ranked #29.

Exome Asset Management first reported a position in ADAG in Q1 2024 and has held it in 5 quarters since. 25 funds tracked by Wall St. Rank hold ADAG as of Q1 2026.

  • Exome Asset Management held 736,845 shares of Adagene worth $2.89M as of Q1 2026.
  • Exome Asset Management sold 323,376 Adagene shares in Q1 2026, an estimated $936K.
  • Adagene made up 1.49% of Exome Asset Management's portfolio in Q1 2026, its #29 holding.
  • Exome Asset Management first reported a position in Adagene in Q1 2024 and has held it in 5 quarters since.
  • 25 funds tracked by Wall St. Rank held Adagene as of Q1 2026.

Based on Exome Asset Management's 13F filing for Q1 2026, filed 15 May 2026.